PAR 8.00% 23.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice, page-13

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    PARs financial predicament doesnt really factor into the issuance of these shares. it doesn't cost the company any cash although continues to dilute existing holders. I think as one person said before...... we're in the wrong business.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.